Al18F-NOTA-奥曲肽PET/CT与18F-FDG PET/CT检测Von Hippel-Lindau病患者小脑血管母细胞瘤
一例42岁Von Hippel-Lindau病男性患者,有胰腺神经内分泌肿瘤和肾透明细胞癌手术史,为评估潜在转移接受Al18F-NOTA-奥曲肽和18F-FDG PET/CT检查。18F-FDG PET/CT显示右侧小脑低摄取,而Al18F-NOTA-奥曲肽摄取增高,小脑肿块切除后病理符合血管母细胞瘤。本病例报告提示Al18F-NOTA-奥曲肽在血管母细胞瘤诊断中有重要作用。
要点
- 18F-FDG PET/CT示右侧小脑低摄取,Al18F-NOTA-奥曲肽PET/CT示该处摄取增高。
- 小脑肿块切除后病理符合血管母细胞瘤。
- 病例报告提示Al18F-NOTA-奥曲肽在血管母细胞瘤诊断中有重要作用。
核心结论
- 本病例报告提示Al18F-NOTA-奥曲肽在血管母细胞瘤诊断中有重要作用。
研究设计与样本
- 本文为病例报告,对象为1例42岁有Von Hippel-Lindau病病史的男性患者。
主要发现
- 患者有胰腺神经内分泌肿瘤和肾透明细胞癌手术史,为评估潜在转移接受Al18F-NOTA-奥曲肽和18F-FDG PET/CT检查。
- 18F-FDG PET/CT显示右侧小脑低摄取,而Al18F-NOTA-奥曲肽在该处活性增高。
- 行小脑肿块切除手术,病理结果符合血管母细胞瘤。
关键数值与推荐
- 18F-FDG PET/CT示右侧小脑低摄取,Al18F-NOTA-奥曲肽PET/CT示该处摄取增高。
- 小脑肿块切除后病理结果符合血管母细胞瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Von Hippel-Lindau disease is a hereditary syndrome associated with various benign and malignant tumors, including hemangioblastomas. A 42-year-old man with a history of Von Hippel-Lindau disease underwent surgery for pancreatic neuroendocrine tumor and renal clear cell carcinoma and was recommended to undergo Al18F-NOTA-octreotide and 18F-FDG PETCT examination to assess potential metastases. 18F-FDG PET/CT showed low uptake in the right cerebellum, which demonstrated increased Al18F-NOTA-octreotide activity. Cerebellar mass resection surgery was performed. Pathological result was consistent with hemangioblastoma. This case report indicates the significant role of Al18F-NOTA-octreotide in the diagnosis of hemangioblastoma.
引用
- Hou G, Cheng X, Chi Y, et al. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease. Clin Nucl Med. 2024. PMID: 38306383. doi:10.1097/RLU.0000000000005042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。